Newsfeeds - Spark Newswire

2 minute read

Immutep Announced New Collaboration with Merck KGaA, Darmstadt, Germany for LAG-3 Therapy, Efti

Today, 4:46 PM

Immutep Limited (NASDAQ: IMMP) announces a new collaboration and supply agreement with Merck KGaA , Darmstadt, Germany (OTC: MKGAF) for a Phase I/IIa clinical trial in patients with solid tumours, calledINSIGHT-005.

IMMP

7 minute read

The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes

By Shanthi Rexaline

Today, 4:46 PM

After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-specific news flow dictated stock moves during the week.

ADAP

2 minute read

Uncategorized

Immutep Granted Chinese Patent for Eftilagimod Alpha in Chemo-Immunotherapy Combination

By Charles Gross

Today, 4:46 PM

Immutep Limited (NASDAQ: IMMP) is pleased to announce the grant of a new patent (numberZL201480073584.3) entitled "Combined Preparations for the Treatment of Cancer" by the Chinese Patent Office.

IMMP